Up-to-date access to technology licensing opportunities worldwide.
Displaying 1..5 of 5 -
per page
Order by
OTC products ready for registration or in late stage development and molecules with Rx-to-OTC switch potential.
More
In-licensing injectables andoral medicines for the hospital market, originals for orphan/nichemarkets
More
Phase III and beyond prescription products are sought to in-license into the four major Nordic countries.
More
Leiras Finland is looking to in-license new prescription products for the Nordic region including Finland, Sweden, Norway and Denmark.
More
Our analgesic specialists are seeking a new, innovative and novel patch product for the treatment of pain to add to their portfolio.
More
Displaying 1..5 of 5 -
per page
Order by
Oct 2010 - 53 pages - $1,000
Apr 2010 - 22 pages - $99
Jun 2006 - 1068 pages - $2,495
Sep 2011 - 97 pages - $3,500
Feb 2011 - 75 pages - $1,000
Jul 2011 - 74 pages - $3,800
Nov 2010 - 3470 pages - $1,495
Nov 2010 - 77 pages - $1,495